|
HS Code |
657798 |
| Iupac Name | Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate |
| Molecular Formula | C18H21NO6 |
| Molecular Weight | 347.37 g/mol |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO, methanol |
| Smiles | COC(=O)C1=CN(C(=O)C=C1OCc2ccccc2)CC(CO)O |
| Inchi | InChI=1S/C18H21NO6/c1-24-18(23)15-11-19(10-14(21)12-22)16(20)9-13(15)25-8-17-6-4-3-5-7-17/h3-7,9,11,14,21-22H,8,10,12H2,1-2H3 |
| Purity | Typically >95% |
| Storage Conditions | Store at -20°C, protected from light and moisture |
As an accredited Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate, with tamper-evident cap. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): 8,000–9,000 kg net, packed in 25 kg fiber drums, ensuring secure chemical transport and storage. |
| Shipping | This chemical is shipped in a tightly sealed container, protected from light and moisture. It is handled as a non-hazardous organic compound, but standard precautions are taken. The package includes appropriate labeling, safety documentation (SDS), and temperature control if required. Shipping complies with relevant transport regulations for laboratory chemicals. |
| Storage | Store **Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate** in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep at 2–8 °C (refrigerator) unless otherwise specified. Avoid exposure to strong oxidizing agents and acids. Clearly label the container, and ensure access is limited to trained personnel. |
| Shelf Life | Shelf life: Stable for 2–3 years when stored in a cool, dry place, protected from light and moisture, in tightly sealed containers. |
|
Purity 98%: Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high-yield and minimal byproduct formation. Stability temperature 120°C: Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate at stability temperature 120°C is used in medicinal compound manufacturing, where it provides consistent performance under elevated processing conditions. Melting point 144-146°C: Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate with melting point 144-146°C is used in solid formulation development, where it facilitates precise dosing and reproducible tablet formation. Molecular weight 371.37 g/mol: Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate with molecular weight 371.37 g/mol is used in pharmacokinetic studies, where accurate calculation of dosing regimens is achieved. Solubility in DMSO 50 mg/mL: Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate with solubility in DMSO 50 mg/mL is used in high-throughput screening assays, where it enables efficient compound delivery and assay reliability. |
Competitive Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
After years spent on the production floor and in the lab, it’s easy to recognize when a molecule ends up making a difference for end-users across pharmaceutical research and specialty chemical projects. Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate is one of those compounds. As the manufacturer directly overseeing every step of its development, we have found both the science and the logistics behind it to require equal amounts of precision and care.
For many outside a chemical plant, a new product can seem like just a line in a catalog. Beneath every batch number sits a series of refining steps undertaken by skilled teams, who know that even a minor deviation can skew activity, purity, or reproducibility—fundamentals that define our reputation. Over the last decade, our synthesis approach for this pyridine derivative has involved steady tuning. Decisions on solvent systems, purification routes, and temperature controls spring from close monitoring of both classical parameters and unexpected process deviations.
Every raw material entering our synthesis chain comes with a traceable record. We keep our source networks close, after seeing too often how cost-cutting at the supply end leads to headaches in the reactor. Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate draws on starting materials that we vet for identification, moisture level, and consistency before accepting a single drum. Even a skilled chemist faces setbacks if a single input drifts outside its allowed tolerance, risking downstream crystallization or unwelcome side reactions.
Lab reports provide only a partial window into the real quality of a batch. Every lot of our pyridine ester undergoes not only NMR and HPLC checks but also rigorous visual inspections, moisture determination, and residual solvent analysis. We train our operators to note crystals, colors, and odors—details that machines miss. Customers have shared stories where a shade in powder tint helped unmask a trace impurity, saving them days in purification. It’s why we set aside volume for internal retention per batch, so any question can be traced right back to a physical sample held in our controlled storage.
We convey product in sealed HDPE drums or glass bottles, offering multiple pack sizes, and, for particularly humidity-sensitive research destinations, we use desiccant packs and tamper-evident seals. Customers have requested QA data broadened over the years, not only purity but also particle size distribution and bulk density, as physical properties influence both solubility and dosing. Real-world impact emerges whenever a team using automated weighing systems avoids clumping or bridging in process hoppers—outcomes linked directly to how the product was dried, milled, and packed at our facility.
This compound sits at the intersection of medicinal chemistry and chemical biology. One market segment looks for robust building blocks for synthesis, another aims for highly specific intermediates in early-stage drug candidates. Synthetic chemists tend to ask for well-documented chemical reactivity profiles—what we’ve seen, for example, is that the benzyloxy substituent can serve as both a handle and a protective group, featuring mild deprotection under hydrogenolysis. This helps streamline routes to target scaffolds that include the pyridine ring, where selectivity is critical.
Over the years, we’ve worked closely with university labs and pilot pharmaceutical plants. Sometimes, teams report unique challenges that come up during scale-up: solubility shifts or incompatibility with alternative coupling agents. Because we keep synthesis logs for every run—including atmospheric conditions and filtration times—we can often help troubleshoot these process-specific questions. A recent collaboration revealed that a subtle adjustment to the final crystallization solvent improved their downstream yield by several percentage points, simply because our staff had captured data that shed light on a precipitation quirk.
We structure our packaging to ease handling in both small-scale research and pre-production environments. Tight sealing and chemical compatibility play critical roles in protecting against residual atmospheric water, which holds special importance for intermediates sensitive to hydrolysis. After hearing from a customer whose prior supplier delivered material degraded by humid shipping, we shifted our own packaging approach—using low-water activity storage and secondary containment when the compound moves through areas prone to dampness.
One lesson stands out from repeated interaction with clients: direct manufacturers can recognize and adapt to feedback far faster than distributors. We aren’t abstracted from the process, and we see how minute batch differences translate into time and money for research or scale-up. If a user has run into caking in long-term storage, or inconsistency in melting point over several orders, we have the leeway to review historic process data, tweak drying times, or even pilot alternative stabilizers based on lessons learned with related structures. Every inquiry strengthens our process map for future lots.
This direct involvement means we can evaluate new regulatory or sustainability guidelines as soon as they affect our upstream purchases or downstream waste handling. Safety standards shift over time—the expectations for trace solvent content or permissible exposure thresholds, for example—but when those updates come through, our in-house regulatory team can assess lifecycle data and adapt instructions without a lag. This means research teams don’t have to worry about sudden out-of-spec material popping up out of the blue because their supplier didn’t catch a compliance change soon enough.
We believe transparency stands at the core of trust. We maintain a clear chain of custody on every batch, not just on paper, but through digital records that backtrack to our raw material intake. At several points over the last decade, this approach has helped customers avoid the kind of bottlenecks that develop when a critical intermediate fails a documentation check or exhibits an unexplained batch-to-batch variance. Our QA group pushes for constant upgrades—sometimes at odds with short-term margins—because skipping steps to save on time or testing ends up costlier over a longer horizon.
This pyridine carboxylate features unique chemical handles compared to many structurally-similar intermediates. Chemists familiar with more basic methyl esters notice the role of the benzyloxy and dihydroxypropyl groups in opening up pathway flexibility. For instance, the benzyloxy substituent persists through a range of reaction environments but offers a reversible protection strategy that doesn’t overcomplicate purification. Some earlier synthetic approaches depended on less stable groups, which risked unwanted cleavage or side reactions under hydrogenation.
Compared to broad-spectrum pyridine esters, this compound’s dihydroxypropyl functionality provides both solubility tuning and access to downstream derivatizations such as phosphorylation or acylation. These features reduce the upstream workload for drug design projects targeting bioactive analogs or small-molecule libraries. Our experience tells us that compounds lacking these features often force researchers to tack on extra synthetic steps, burning through more reagents and time for each iteration.
Formulation scientists have noted differences in solubility profiles and processability when benchmarking this compound next to standard 1,4-dihydropyridine building blocks. For teams developing new active substances, even subtle differences—like improved dissolution in mixed organic/aqueous systems—cut down method development time. They don’t need to re-invent their purification workflows with every new intermediate because our manufacturing consistency reduces their project’s operational risk.
We keep track of feedback from research-scale to kilogram-scale users. Whenever a customer shares that our batch has enabled smoother handling or improved conversion in critical steps, we run a retrospective to confirm whether the same benefit holds across future lots. That direct line of communication distinguishes what a manufacturer can offer: real knowledge, with the accountability to back up claims with production logs and corrective action where necessary.
It’s easy to promise high purity and optimal specifications in a brochure—but one discovers the true nature of a product only under the demanding conditions of an R&D lab or pilot line. Experience has taught us to pay close attention to nuances in stability, reactivity, and longevity. Maintaining crystalline integrity, for example, often hinges on controlling both solvent composition during final isolation and the drying atmosphere. Every so often, a minor shift in plant humidity or a spike in ambient temperature teaches us how tightly physical properties depend on day-to-day manufacturing diligence.
Customers testing our product in combinatorial synthesis or solid-phase processes often share details about filtration behavior or reactivity with standard protecting groups. One found faster conversion rates versus an older supplier’s lot, tying the improvement to closer particle size control on our end. We constantly monitor these trends, knowing well that small deviations from spec can create wasted effort or delay downstream compounds by months, especially in pharmaceutical workflows where timelines already run tight.
We field questions around product lifespan or stability once it reaches distant destinations. Hot, humid transit routes risk hydrolytic degradation, and improperly sealed containers can introduce unwanted variability. We adjusted our post-production logistics to include climate-controlled storage, upgraded dessicant use, and a no-shortcuts shipment protocol for sensitive destinations. This came about after a pair of overseas research centers reported slight but consistent drops in active ingredient content over long ocean shipping. Their feedback prompted both packaging and process changes that later helped avoid similar issues elsewhere, demonstrating a chain of continuous improvement rooted in real user experiences.
Our chemists and process engineers have learned that tailoring a synthetic route or updating impurity profiles is only part of the job. Supporting those who work downstream with hands-on advice and rapid troubleshooting turns data sheets into genuine product value. More than once, we have run short-turnaround reprocessing or custom formulation services for partners scaling up to pilot production, based purely on their need for specific particle morphology or tailored physical properties. At our site, collaboration means more than marketing speak—it trickles into every QA check, every batch log, and every review after shipment.
Across dozens of research collaborations, a clear trend emerges: the fastest breakthroughs stem from direct data and open dialogue. Pharmaceutical and fine chemical projects rarely proceed in a straight line, with every new route throwing up fresh compatibility, reactivity, or analytical puzzles. By acting as both producer and troubleshooting partner, we can apply years of lessons learned to short-circuit chemical bottlenecks before they drive up costs or derail schedules.
Market feedback pushes the boundaries of what a manufacturer can offer. As new drug modalities and synthetic techniques emerge, pure analytical or documentation support only scratches the surface. We stay active in pilot collaborations, where regular exchanges with R&D teams challenge us to think creatively about impurity removal, process robustness, and cost-effective scaling. Compound performance in automated systems or unconventional reactors leads to internal process innovation: new drying systems, updated grinding setups, or gen-two packaging designed for pristine recovery and dosing accuracy.
As environmental regulations grow more complex, source material transparency gains new urgency. Our supply chain teams monitor evolving benchmarks, so a partner researching environmental impacts or applying for green chemistry incentives can back every claim with real production data. Collaborations with regulatory bodies and external audit partners integrate seamlessly within our operation, giving users greater confidence that product batches align with fast-changing standards in safety and sustainability. Engineers citing concerns over solvent offset or greenhouse gas potential know they will receive an honest breakdown of our pathway’s footprint—not just marketing-friendly claims.
Focusing on hands-on chemical production has given our staff a unique perspective on compound lifecycle. Every time a client encounters unexpected stability questions, tricky filtrations, or scaling headaches, our ability to revisit the process with genuine authority reduces troubleshooting cycles. This ownership speeds up corrective action, eliminates layers of miscommunication, and ensures that the product reaching your workbench reflects all of the lessons learned since its very first batch. Our approach builds resilience—not just into the chemistry, but into the relationships that power breakthroughs in every downstream application.
Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate, forged under real manufacturing scrutiny, carries evidence of every process trial and every user insight. Those investing in advanced synthesis, from discovery labs to process lines, get more than a static catalog entry; they get a transparent, responsive supply chain, guided by a genuine commitment to consistency and continuous learning. We value every opportunity to adapt, improve, and report the realities behind the glossy facade of chemical innovation. Our mission stays rooted in concrete outcomes: predictable quality, attentive support, and the willingness to evolve alongside discovery itself.